← Leaderboards
Ben Cravatt
University Of Washington
$32,197
Attributed
$32,197
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $20.1K · FY2005–09$25K$18.8K$12.5K$6.3K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$32,197 · 5
By mechanism
P41$32,197 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Trisha N. Davis$18,189,606
- William Noble$1,403,272
- Dustin J Maly$15,468,910
- Stanley Fields$11,380,548
- Michael H Gelb$24,827,130
Others in their field
Top investigators on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$642,073,624
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$513,687,120
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United States National Institutes Of HealthCell GrowthResourcesSourceTumorComputer Retrieval Of Information On Scientific Projects DatabaseEnzymesFundingGlycolysis PathwayGrantInhibitor/AntagonistInstitutionLaboratoriesPhosphoglycerate MutaseResearch PersonnelCell Line, TumorBiomedical ComputingTumor Cell Line
Grant awards (5)
NOVEL MODULATORS OF GLYCOLYSIS PATHWAY ENZYMES$3,181
P41 · FY2009 · RR · contact PI
NOVEL MODULATORS OF GLYCOLYSIS PATHWAY ENZYMES$3,233
P41 · FY2008 · RR · contact PI
NOVEL MODULATORS OF GLYCOLYSIS PATHWAY ENZYMES$1,774
P41 · FY2007 · RR · contact PI
A STREAMLINED PLATFORM FOR HIGH-CONTENT FUNCTIONAL PROTEOMICS OF PRIMARY HUMAN$20,051
P41 · FY2006 · RR · contact PI
CARCINOMA AND STROMAL ENZYME ACTIVITY PROFILES ASSOCIATED WITH BREAST TUMOR GRO$3,958
P41 · FY2005 · RR